Professional Documents
Culture Documents
Soal Dan Jawaban Tugas Lab 8 - IPT Bonds
Soal Dan Jawaban Tugas Lab 8 - IPT Bonds
TUGAS LAB 8
INTERCOMPANY PROFIT TRANSACTIONS - BONDS
In 2028, PT Adhi Medika Indonesia (Adhimed) and PT Indolab Maju continued their
business as usual and maintained their accounting reports separately. During the year, PT Adhimed
made total sales of Rp60.200.000.000, as much as 40% of those sales were paid in cash and the rest
were on credit. Included in those sales were transactions made to PT Indolab Maju amounted to
Rp9.545.000.000 on account. The cost of sales for sales made to PT Indolab Maju was
Rp3.525.000.000. PT Adhimed also received a settlement of 50% for its accounts receivable
(including balance from inventory sales in 2027) and 32% for the note receivable (ignore the
interest effect in this transaction) in the beginning of 2028. The company also paid 56% of its
accounts payable and 40% of its mortgage payable from the balances from the balance at the
beginning of 2028. To expand its business, on January 10, 2028, PT Adhimed issued
Rp4.000.000.000 par of 10%, a 5-year bond that was sold for RpRp4.220.000.000. PT Adhimed
also made a total purchase of inventory from its suppliers as much as Rp32.000.000.000, with
32,8% of the purchase were paid in cash and the rest were on account. Included in those
transactions were purchases made from PT Indolab Maju for Rp6.000.000.000 which were all on
credit. PT Adhimed had total operating expenses (excluding the cost of sales) of
Rp9.962.800.000. Other expenses amounted to Rp1.450.000.000 were included in those
expenses and were paid in cash by PT Adhimed. PT Adhimed distributed Rp26.000.000.000
cash dividends near the end of the year. At year-end, PT Adhimed’s stock opname showed that
there was Rp23.322.000.000 worth of inventories left in its warehouse. Included in those ending
inventories were 20% of inventories bought from PT Indolab Maju. In 2028, the company’s
affiliate, PT Berkah Medika obtained a net profit of Rp2.100.000.000 and distributed cash
dividends to shareholders of Rp700.000.000. The other balances remained the same.
PT Indolab Maju made total sales in 2028 amounting Rp22.000.000.000 with as much as
65% of the total sales paid in cash and the rest on account. Including in those sales, there
were transactions made to PT Adhimed for Rp6.000.000.000 on account. The cost of sales
made to PT Adhimed was Rp3.750.000.000. PT Indolab Maju received settlement for 60% of
its accounts receivable and 75% of its notes receivable (ignore the interest effect in this transaction)
from the beginning balances in 2028. PT Indolab Maju also paid off 75% of its accounts payable
and 70% of its mortgage payable from the beginning balances in 2028.
Additional Information:
PT Adhimed
Book Value on Jan 1, 2028. Remaining Useful Life
PT Indolab Maju
Book Value on Jan 1, 2028 Remaining Useful Life
Required:
Prepare the separate financial statements consisting of Statement of Profit or Loss, Retained
Earnings Statement, and Statement of Financial Position for PT Adhi Medika Indonesia and PT
Indolab Maju on December 31, 2028, and provide the supporting calculations and journal entries
for issuance and investment on PT Adhi Medika Indonesia’s Bonds. Do not round off your
answers! (Hint: for the beginning of 2028 financial statements, use the separate financial
statements on December 31, 2027, which were your answers in Assignment 7).
Hint*:
- Make sure when calculating Constructive gain/loss, the Book Value of the bonds payable
was the value at July 1, 2028
*Make sure your answers are in accordance to the above hints as they will be used in Latihan
Lab 8
1. Preliminary Computation
PT Adhimed
Issuance of Adhimed’s Bonds on January 10, 2028 (In Million)
𝑅𝑝220
𝐴𝑚𝑜𝑟𝑡𝑖𝑧𝑒𝑑 𝑃𝑟𝑒𝑚𝑖𝑢𝑚 = = 𝑅𝑝44 𝑝𝑒𝑟 𝑦𝑒𝑎𝑟
5 𝑦𝑒𝑎𝑟𝑠
PT Indolab Maju
Purchasing 10% of Adhimed’s Bonds on July 1, 2028 (In Million)
𝑅𝑝14,4
𝐴𝑚𝑜𝑟𝑡𝑖𝑧𝑒𝑑 𝐷𝑖𝑠𝑐𝑜𝑢𝑛𝑡 = = 𝑅𝑝3,2 𝑝𝑒𝑟 𝑦𝑒𝑎𝑟
4,5 𝑦𝑒𝑎𝑟𝑠
Consolidated
𝑅𝑝34,20
𝑃𝑖𝑒𝑐𝑒𝑚𝑒𝑎𝑙 𝐴𝑚𝑜𝑟𝑡𝑖𝑧𝑒𝑑 = = 𝑅𝑝7,6 𝑝𝑒𝑟 𝑦𝑒𝑎𝑟
4,5 𝑦𝑒𝑎𝑟𝑠
PT Adhimed
PT Indolab
Add:
Other Current Assets 600,00 200,00
Land 1.128,75 376,25
Unamortized Building 978,00 326,00
Other Liabilities 112,50 37,50
Constructive Gain 30,40
Goodwill 2.036,25 678,75
Less:
Unamortized Equipment (618,00) (206,00)
Unrealized profit in Indolab Maju's Inventories
on Dec 31, 2028 - Downstream (1.204,00)
Unrealized profit in Adhimed's Inventories on
Dec 31, 2027 - Upstream (337,50) (112,50)
Unrealized Gain on Sale of Land (Downstream) (120,00)
OR
PT INDOLAB MAJU
Statement of Profit or Loss
For the Year Ended December 31, 2028 (in Million Rupiah)
Sales 22.000,00
Interest Revenue 21,6
Total Revenues 22.021,60
PT INDOLAB MAJU
Retained Earnings Statement
For the Year Ended December 31, 2028 (in Million Rupiah)
Beginning Retained Earnings 36.188,20
Add: Net Income 2.334,10
Less: Dividends 420
Retained Earnings, Dec 31 38.102,30
PT INDOLAB MAJU
Statement of Financial Position
December 31, 2028 (in Million Rupiah)
Assets
Cash 23.465,202
Accounts Receivable-net 12.926,048
Interest Receivable 20,00
Inventories 2.820,00
Other Current Asset 2.084,100
Notes Receivable-net 325,00
Land 15.055,00
Buildings-net 14.160,00
Equipment-net 30.180,00
Investment in Bonds Adhimed 387,200